Sara Moss to Retire From the Estée Lauder Companies
25.4.2023 16:05:00 EEST | Business Wire | Press release
Today, The Estée Lauder Companies Inc. (NYSE:EL)("ELC") announced that Sara Moss, Vice Chairman, The Estee Lauder Companies, has made the decision to retire, effective July 1, 2023.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230425005169/en/
Sara Moss to retire from The Estée Lauder Companies
Sara’s outstanding career with The Estée Lauder Companies began in 2003 when she joined the organization as Executive Vice President and General Counsel, a position she served in until 2019 when she was promoted to Vice Chairman. A recognized thought leader, collaborative partner, and keen legal and business strategist, Sara served as a trusted advisor to the business, the Board of Directors and the Lauder Family throughout her tenure.
“Sara is an exceptional legal mind, a skilled advisor, a valued mentor, and a much-loved leader whose strategic insights, business acumen and sound judgment have contributed greatly to our company’s success,” said Fabrizio Freda, President and Chief Executive Officer. “Her incredible character, steadfast integrity and deep empathy will be greatly missed across the organization.”
As General Counsel, Sara led the Global Legal function, as well as the Corporate Security function, during a period of enormous growth in the business and operations of ELC. She prioritized business acumen and dedicated lawyers to each brand, region and function to support the growth and protection of the enterprise with local relevance. Notably, she oversaw the function’s initial international expansion into Europe, Asia, the Middle East, and Latin America, and collaborated closely with senior management and teams across the enterprise to execute many business-driving acquisitions, investments, and licenses of global luxury and prestige brands.
Sara has been a true champion of the company’s initiatives in Inclusion, Diversity and Equity and philanthropy. She was an inaugural member of the Diversity Council and the first Executive Sponsor of the Hispanic Connection Employee Resource Group. In 2019, she joined Jane Hertzmark Hudis, Executive Group Brand President, and Tracey T. Travis, Executive Vice President and Chief Financial Officer, as Co-Executive Sponsor of the Women’s Leadership Network (WLN). She has been a Board member of the ELC Charitable Foundation since its inception.
Upon her promotion to Vice Chairman in 2019, Sara served as a senior advisor to Executive Management, the Board of Directors, and the Lauder Family, working on a wide range of matters to strategically support the company’s long-term sustainable success.
“A trusted senior business advisor for many years, Sara has nurtured strong relationships within our global ELC family and across the wider industry,” said William P. Lauder, Executive Chairman. “It is with great appreciation, admiration, and respect that I say her dynamic leadership and expert guidance will be truly missed.”
A passionate proponent of women’s advancement, Sara partnered closely with senior leaders across the organization to drive the company’s first Women’s Advancement and Gender Equality Strategy in 2019. She demonstrated her deep commitment to supporting and engaging women to reach their full potential as leaders by creating the Open Doors Women’s Leadership Program in 2020, to help develop leadership skills, create community, and build confidence and courage among aspiring leaders across the business. In 2022, the Open Doors Collection was launched to bring these leadership skills and experiential approach to ELC employees of all genders around the world.
For the past three years, Sara also led the Social Impact pillar of the company’s integrated ESG strategy, including Women’s Advancement and Gender Equality, Racial Equity, Generational Diversity and Social Impact in China.
Sara’s impact extends far beyond the walls of ELC. In 2017 she established the Sara Moss Women’s Leadership Program at New York University Law School – her alma mater – where she also serves as a Law School Trustee and member of the Board of Directors. She is Vice Chairman of the Board of The New York Common Pantry, where she was recognized with the Distinguished Partner Award in 2020. Additionally, she serves on the Advisory Boards of the International Rescue Committee (IRC) and The Legal Aid Society. Sara has received many well-deserved honors in recognition of her outstanding career and tireless service, including the New York Journal Lifetime Achievement Award, the Legal Aid Society Servant of Justice Award, the NOW Legal Defense and Education “Aiming High” Award and the NYU Outstanding Alumna Award.
“Sara will be leaving a legacy of true dedication, passion, and professionalism at ELC,” said Leonard A. Lauder, Chairman Emeritus. “On behalf of the company and the entire Lauder family, I would like to thank Sara for her tremendous contributions to our business over the past 20 years and wish her the very best in her well-deserved retirement.”
About The Estée Lauder Companies Inc.
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance, and hair care products. The Company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD BEAUTY, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD.
ELC-C
ELC-L
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230425005169/en/
Contact information
Media Relations:
Jill Marvin
jimarvin@estee.com
Investor Relations:
Rainey Mancini
rmancini@estee.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
